| 1.2 -0.01 (-0.83%) | 11-20 16:00 | |||||||||||||
|
|
| Short term | ||||
| Mid term | |
|||
| Targets | 6-month : | 1.47 |
1-year : | 1.65 |
| Resists | First : | 1.25 |
Second : | 1.41 |
| Pivot price | 1.21 |
|||
| Supports | First : | 1 |
Second : | 0.83 |
| MAs | MA(5) : | 1.26 |
MA(20) : | 1.19 |
| MA(100) : | 0.92 |
MA(250) : | 1.29 |
|
| MACD | MACD : | 0 |
Signal : | 0 |
| %K %D | K(14,3) : | 54 |
D(3) : | 62.1 |
| RSI | RSI(14): 52.9 |
|||
| 52-week | High : | 3 | Low : | 0.61 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ DH ] has closed above bottom band by 43.3%. Bollinger Bands are 18.5% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 1.24 - 1.24 | 1.24 - 1.25 |
| Low: | 1.13 - 1.14 | 1.14 - 1.15 |
| Close: | 1.19 - 1.2 | 1.2 - 1.21 |
Definitive Healthcare Corp. (DH), operating through its various subsidiaries, offers specialized commercial intelligence solutions for the U.S. healthcare industry. The company's services furnish essential data on healthcare providers and their activities, enabling clients to navigate critical business processes, from the early stages of product development to strategic market entry planning and effective sales and marketing execution. Its sophisticated platform incorporates sixteen distinct intelligence modules. These modules are designed to support key functional domains such as sales optimization, marketing initiatives, clinical research, new product creation, strategic planning, human capital acquisition, and the oversight of physician networks. Definitive Healthcare caters to a broad spectrum of clients, including biopharmaceutical firms, medical device manufacturers, healthcare information technology companies, and direct healthcare providers. Additionally, its clientele extends to diverse organizations within the wider healthcare ecosystem, such as staffing and commercial real estate companies, financial institutions, and other related entities. Founded in 2011, Definitive Healthcare Corp. is headquartered in Framingham, Massachusetts.
Mon, 16 Nov 2026
DH: Definitive Healthcare Corp - Ordinary Shares - Class A Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits
Thu, 05 Nov 2026
Definitive Healthcare Corp. (DH) Tops Q3 Earnings and Revenue Estimates - Yahoo Finance
Wed, 02 Sep 2026
Definitive Healthcare rises on buyout offer from Advent International - Seeking Alpha
Mon, 10 Aug 2026
Definitive Healthcare Corp. (DH) Q2 Earnings Surpass Estimates - Yahoo Finance
Tue, 26 May 2026
DH - Definitive Healthcare Corp Stock Price and Quote - Finviz
Tue, 12 May 2026
Definitive Healthcare: When The Anchor Shareholder Walks, Pay Attention (NASDAQ:DH) - Seeking Alpha
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Healthcare Information Services
|
|
| Shares Out | 107 (M) |
| Shares Float | 40 (M) |
| Held by Insiders | 6.1 (%) |
| Held by Institutions | 82.8 (%) |
| Shares Short | 1,930 (K) |
| Shares Short P.Month | 1,820 (K) |
| EPS | -1.5 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 2.7 |
| Profit Margin | -72.3 % |
| Operating Margin | -8.6 % |
| Return on Assets (ttm) | -2 % |
| Return on Equity (ttm) | -78.4 % |
| Qtrly Rev. Growth | -9.2 % |
| Gross Profit (p.s.) | 1.81 |
| Sales Per Share | 2.17 |
| EBITDA (p.s.) | 0.32 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 41 (M) |
| Levered Free Cash Flow | 50 (M) |
| PE Ratio | -0.81 |
| PEG Ratio | 0 |
| Price to Book value | 0.44 |
| Price to Sales | 0.55 |
| Price to Cash Flow | 3.1 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |